Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2008 Sep 30;39(7):373–376. [Article in Spanish] doi: 10.1157/13107726

Estatinas en la prevención secundaria del ictus en la comunidad

Luis Castilla-Guerra a,⁎, Manuel Balbuena García b, María del Carmen Fernández-Moreno c
PMCID: PMC7664541  PMID: 17669322

The content is available as a PDF (113.1 KB).

Bibliografía

  • 1.Instituto Nacional de Estadística [citado Dic 2006]. Disponible en: http://www.ine.es
  • 2.Hankey G.J. Secondary prevention of recurrent stroke. Stroke. 2005;36:218–221. doi: 10.1161/01.STR.0000153048.87248.3b. [DOI] [PubMed] [Google Scholar]
  • 3.Dhamoon M.S., Sciacca R.R., Rundek T., Sacco R.L., Elkind M.S.V. Recurrent stroke and cardiac risks after first ischemic stroke. TheNorthern Manhattan Study. Neurology. 2006;66:641–646. doi: 10.1212/01.wnl.0000201253.93811.f6. [DOI] [PubMed] [Google Scholar]
  • 4.Castilla-Guerra L., Espino-Montoro A., Fernández-Moreno M.C., López-Chozas J.M., Jiménez M.D. Statins and stroke. Currentclinical practice. Stroke. 2006;37:1153. doi: 10.1161/01.STR.0000217462.54003.43. [DOI] [PubMed] [Google Scholar]
  • 5.Ovbiagele B., Saver J.L., Bang H., Chambless L.E., Nassief A., Minuk J. Statins treatment and adherence to national colesterol guidelines after ischemic stroke. Neurology. 2006;66:1164–1170. doi: 10.1212/01.wnl.0000208403.18885.0e. [DOI] [PubMed] [Google Scholar]
  • 6.Sacco R.L., Adams R., Alberts G., Alberts M.J., Benavente O., Furie K. Guidelines for stroke prevention of stroke in patients with ischemic stroke or transient isquemic attack. Stroke. 2006;37:577–617. doi: 10.1161/01.STR.0000199147.30016.74. [DOI] [PubMed] [Google Scholar]
  • 7.Prospective Studies Collaboration Cholesterol, diastolic bloodpressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647–1653. [PubMed] [Google Scholar]
  • 8.Vivancos-Mora J., Gil-Núñez A.C. Lipids and stroke: the opportunity of lipid-lowering treatment. Cerebrovasc Dis. 2005;20(Suppl 2):53–67. doi: 10.1159/000089357. [DOI] [PubMed] [Google Scholar]
  • 9.Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994;344:1383–1389. [PubMed] [Google Scholar]
  • 10.Byington R.P., Davis B.R., Plehn J.F., White H.D., Baker J., Cobbe S.M. for the PPP Investigators The Prospective Pravastatin Pooling (PPP) Project. Circulation. 2001;103:387–392. doi: 10.1161/01.cir.103.3.387. [DOI] [PubMed] [Google Scholar]
  • 11.Waters D.D., Schwartz G.G., Olsson A.G., Zeiher A., Oliver M.F., Ganz P. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation. 2002;106:1690–1695. doi: 10.1161/01.cir.0000031568.40630.1c. [DOI] [PubMed] [Google Scholar]
  • 12.Sever P.S., Dahof B., Poulter N.R., Wedel H., Beevers G., Caufield M. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentrerandomised controlled trial. Lancet. 2003;361:1149–1158. doi: 10.1016/S0140-6736(03)12948-0. [DOI] [PubMed] [Google Scholar]
  • 13.Colhoun H.M., Betteridge D.J., Durrington P.N., Neil H.A., Livinstone S.J., Thomason M.J. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–696. doi: 10.1016/S0140-6736(04)16895-5. [DOI] [PubMed] [Google Scholar]
  • 14.LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C. Treating to New Targets (TNT) Investigators Intensiv elipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425–1435. doi: 10.1056/NEJMoa050461. [DOI] [PubMed] [Google Scholar]
  • 15.Amarenco P., Labreuche J., Lavallée P.H., Touboul P.J. Statins in stroke prevention and carotid atherosclerosis. Stroke. 2004;35:2902–2909. doi: 10.1161/01.STR.0000147965.52712.fa. [DOI] [PubMed] [Google Scholar]
  • 16.Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals. A randomised placebo-controltrial. Lancet. 2002;360:7–22. [Google Scholar]
  • 17.Ovbiagele B., Kidwell C.S., Saver J.L. Expanding indications for statins in cerebral ischemia. Arch Neurol. 2005;62:67–72. doi: 10.1001/archneur.62.1.67. [DOI] [PubMed] [Google Scholar]
  • 18.Amarenco P., Bogousslavsky J., Callahan A., Goldstein L.B., Hennerici H., Rudolf A.E. High-dose atorvastatin after stroke or transient ischemic attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. N Engl J Med. 2006;355:549–559. doi: 10.1056/NEJMoa061894. [DOI] [PubMed] [Google Scholar]
  • 19.Kent D.M. Stroke, an equal opportunity for the initiation of statin therapy. N Engl J Med. 2006;355:613–615. doi: 10.1056/NEJMe068146. [DOI] [PubMed] [Google Scholar]
  • 20.Hankey G.J. Statins after transient ischaemic attack and ischaemic stroke. Lancet Neurol. 2006;5:810–812. doi: 10.1016/S1474-4422(06)70559-2. [DOI] [PubMed] [Google Scholar]
  • 21.Ebrahim S., Sung J., Song Y.M., Ferrer R.L., Lwalor D.A., Davey-Smith G. Serum cholesterol, hemorrhagic stroke and myocardial infarction: Korean national heath system prospective cohortstudy. BMJ. 2006;333:22–27. doi: 10.1136/bmj.38855.610324.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fuentes B., Díez Tejedor E., Gil Núñez A., Gil Peralta A., MatíasGuiu J. Guía para el tratamiento preventivo de la isquemia cerebral. In: Díez Tejedor E., editor. Guía para el diagnóstico y tratamiento del ictus. Prous Science; Barcelona: 2006. pp. 133–183. [Google Scholar]
  • 23.Lobos Bejarano J.M., López Rodríguez I., Martí Canales J. OMC y Ministeriode Sanidad y Consumo. IM&C S.A; Madrid: 2006. Guía de buena práctica clínica en prevención del ictus. [Google Scholar]
  • 24.National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterolin Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421. [PubMed] [Google Scholar]
  • 25.Grundy S.M., Cleeman J.I., Merz C.N.B., Brewer H.B., Clark L.T., Hunninghake D.B. Implications of Recent Clinical Trialsfor the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227–239. doi: 10.1161/01.CIR.0000133317.49796.0E. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES